{
    "Trade/Device Name(s)": [
        "Liquichek Immunology Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K130761",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022991"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "March 13, 2013",
    "Summary Letter Received Date": "March 20, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin",
        "Alpha-1-Acid Glycoprotein",
        "Alpha-1-Antitrypsin",
        "Alpha-2-Macroglobulin",
        "Antistreptolysin O",
        "Apolipoprotein A-1",
        "Apolipoprotein B",
        "Beta-2-Microglobulin",
        "C1 Inhibitor",
        "C-Reactive Protein (CRP)",
        "Ceruloplasmin",
        "Complement C3",
        "Complement C4",
        "Cystatin C",
        "Ferritin",
        "Haptoglobin",
        "IgG1 Subclass",
        "IgG2 Subclass",
        "IgG3 Subclass",
        "IgG4 Subclass",
        "Immunoglobulin A",
        "Immunoglobulin E",
        "Immunoglobulin G",
        "Immunoglobulin M",
        "Kappa Light Chain",
        "Lambda Light Chain",
        "Prealbumin",
        "Protein, Total",
        "Retinol Binding Protein",
        "Rheumatoid Factor",
        "Transferrin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Immunology Control, a multi-analyte assayed quality control serum for monitoring immunology and chemistry test precision.",
    "Indications for Use Summary": "Intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the listed analytes.",
    "fda_folder": "Clinical Chemistry"
}